Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Proietti

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Rivista Di Psichiatria|December 22, 2020
Traumatic experiences and type 2 diabetes mellitusAnna Saya, Laura Proietti, Giulia Lisi, et al.
Urology|November 16, 2005
Chromogranin A expression in familial versus sporadic prostate cancerAlessandro Sciarra, Salvatore Monti, Vincenzo Gentile, et al.
European Urology|December 8, 2004
Combination therapy with rofecoxib and finasteride in the treatment of men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH)Franco Di Silverio, Cesare Bosman, Monti Salvatori, et al.
Urologia Internationalis|January 22, 2008
Comparison of chromogranin A, insulin-like growth factor 1 and prostate-specific antigen serum markers in prostate adenocarcinoma and benign prostatic hyperplasiaAlessandro Sciarra, Vincenzo Gentile, Salvatori Monti, et al.
Diabetes|March 2, 2002
Association between a novel variant of the human type 2 deiodinase gene Thr92Ala and insulin resistance: evidence of interaction with the Trp64Arg variant of the beta-3-adrenergic receptorDaniela Mentuccia, Laura Proietti-Pannunzi, Keith Tanner, et al.
Journal of Hepatology|September 7, 2005
An outbreak of hepatitis A virus infection with a high case-fatality rate among injecting drug usersEnea Spada, Domenico Genovese, Maria Elena Tosti, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 3, 2008
Androgen receptor regulation of the seladin-1/DHCR24 gene: altered expression in prostate cancerLorella Bonaccorsi, Paola Luciani, Gabriella Nesi, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Rivista Di Psichiatria|December 22, 2020
Traumatic experiences and type 2 diabetes mellitusAnna Saya, Laura Proietti, Giulia Lisi, et al.
Urology|November 16, 2005
Chromogranin A expression in familial versus sporadic prostate cancerAlessandro Sciarra, Salvatore Monti, Vincenzo Gentile, et al.
European Urology|December 8, 2004
Combination therapy with rofecoxib and finasteride in the treatment of men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH)Franco Di Silverio, Cesare Bosman, Monti Salvatori, et al.
Urologia Internationalis|January 22, 2008
Comparison of chromogranin A, insulin-like growth factor 1 and prostate-specific antigen serum markers in prostate adenocarcinoma and benign prostatic hyperplasiaAlessandro Sciarra, Vincenzo Gentile, Salvatori Monti, et al.
Diabetes|March 2, 2002
Association between a novel variant of the human type 2 deiodinase gene Thr92Ala and insulin resistance: evidence of interaction with the Trp64Arg variant of the beta-3-adrenergic receptorDaniela Mentuccia, Laura Proietti-Pannunzi, Keith Tanner, et al.
Journal of Hepatology|September 7, 2005
An outbreak of hepatitis A virus infection with a high case-fatality rate among injecting drug usersEnea Spada, Domenico Genovese, Maria Elena Tosti, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 3, 2008
Androgen receptor regulation of the seladin-1/DHCR24 gene: altered expression in prostate cancerLorella Bonaccorsi, Paola Luciani, Gabriella Nesi, et al.
Pageof 1